Jan. 13, 2023 |
Jan. 13, 2023 |
B
Purchase
|
MENDLEIN JOHN
Non-Executive Director
|
36,631
+14.9%
5.43
198,906
USD
|
36,631
+14.9%
|
5.43
|
198,906
USD
|
|
Jan. 13, 2023 |
Jan. 11, 2023 |
B
Purchase
|
MENDLEIN JOHN
Non-Executive Director
|
88,048
+55.7%
5.67
499,232
USD
|
88,048
+55.7%
|
5.67
|
499,232
USD
|
|
July 25, 2022 |
July 22, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
620
-0.1%
33.28
20,634
USD
|
620
-0.1%
|
33.28
|
20,634
USD
|
|
July 25, 2022 |
July 22, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
2,703
-0.6%
32.61
88,145
USD
|
2,703
-0.6%
|
32.61
|
88,145
USD
|
|
July 25, 2022 |
July 22, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
2,923
-0.7%
31.33
91,578
USD
|
2,923
-0.7%
|
31.33
|
91,578
USD
|
|
July 25, 2022 |
July 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
19,171
-4.3%
33.07
633,985
USD
|
19,171
-4.3%
|
33.07
|
633,985
USD
|
|
July 25, 2022 |
July 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
10,829
-2.3%
32.54
352,376
USD
|
10,829
-2.3%
|
32.54
|
352,376
USD
|
|
July 8, 2022 |
July 7, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
17,158
-8.7%
30.23
518,686
USD
|
17,158
-8.7%
|
30.23
|
518,686
USD
|
|
July 7, 2022 |
July 6, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
7,842
-4.2%
30.07
235,809
USD
|
7,842
-4.2%
|
30.07
|
235,809
USD
|
|
June 2, 2022 |
June 1, 2022 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
25,000
-11.7%
22.96
574,000
USD
|
25,000
-11.7%
|
22.96
|
574,000
USD
|
|
April 25, 2022 |
April 22, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
838
-0.2%
35.15
29,456
USD
|
838
-0.2%
|
35.15
|
29,456
USD
|
|
April 25, 2022 |
April 22, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
9,162
-2.1%
34.54
316,455
USD
|
9,162
-2.1%
|
34.54
|
316,455
USD
|
|
April 25, 2022 |
April 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
1,003
-0.2%
37.90
38,014
USD
|
1,003
-0.2%
|
37.90
|
38,014
USD
|
|
April 25, 2022 |
April 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
2,220
-0.5%
36.70
81,474
USD
|
2,220
-0.5%
|
36.70
|
81,474
USD
|
|
April 25, 2022 |
April 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
4,062
-0.9%
35.73
145,135
USD
|
4,062
-0.9%
|
35.73
|
145,135
USD
|
|
April 25, 2022 |
April 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
22,715
-4.9%
34.57
785,258
USD
|
22,715
-4.9%
|
34.57
|
785,258
USD
|
|
April 4, 2022 |
April 1, 2022 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
25,000
-11.7%
38.85
971,250
USD
|
25,000
-11.7%
|
38.85
|
971,250
USD
|
|
March 15, 2022 |
March 14, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
100
-0.1%
34.04
3,404
USD
|
100
-0.1%
|
34.04
|
3,404
USD
|
|
March 15, 2022 |
March 14, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
2,960
-1.6%
33.30
98,568
USD
|
2,960
-1.6%
|
33.30
|
98,568
USD
|
|
March 15, 2022 |
March 14, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
2,195
-1.2%
32.49
71,316
USD
|
2,195
-1.2%
|
32.49
|
71,316
USD
|
|
March 15, 2022 |
March 14, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
3,067
-1.6%
31.66
97,101
USD
|
3,067
-1.6%
|
31.66
|
97,101
USD
|
|
March 15, 2022 |
March 14, 2022 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
16,678
-8.1%
30.36
506,344
USD
|
16,678
-8.1%
|
30.36
|
506,344
USD
|
|
March 11, 2022 |
March 10, 2022 |
PS
Planned sale
|
MENDLEIN JOHN
Non-Executive Director
|
12,069
-7.0%
35.48
428,208
USD
|
12,069
-7.0%
|
35.48
|
428,208
USD
|
|
March 11, 2022 |
March 10, 2022 |
PS
Planned sale
|
MENDLEIN JOHN
Non-Executive Director
|
19,493
-10.2%
34.73
676,992
USD
|
19,493
-10.2%
|
34.73
|
676,992
USD
|
|
Jan. 24, 2022 |
Jan. 21, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
10,000
-2.3%
38.02
380,200
USD
|
10,000
-2.3%
|
38.02
|
380,200
USD
|
|
Jan. 24, 2022 |
Jan. 20, 2022 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-6.5%
40.21
1,206,300
USD
|
30,000
-6.5%
|
40.21
|
1,206,300
USD
|
|
Jan. 4, 2022 |
Jan. 3, 2022 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
861
-0.5%
60.31
51,927
USD
|
861
-0.5%
|
60.31
|
51,927
USD
|
|
Jan. 4, 2022 |
Jan. 3, 2022 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
27,812
-14.1%
59.86
1,664,826
USD
|
27,812
-14.1%
|
59.86
|
1,664,826
USD
|
|
Jan. 4, 2022 |
Jan. 3, 2022 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
16,900
-7.9%
58.84
994,396
USD
|
16,900
-7.9%
|
58.84
|
994,396
USD
|
|
Jan. 4, 2022 |
Jan. 3, 2022 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
4,427
-2.0%
57.76
255,704
USD
|
4,427
-2.0%
|
57.76
|
255,704
USD
|
|
Dec. 21, 2021 |
Dec. 20, 2021 |
PS
Planned sale
|
Dulac Edward J III
Chief Financial Officer
Officer
|
15,977
-12.6%
60.00
958,620
USD
|
15,977
-12.6%
|
60.00
|
958,620
USD
|
|
Dec. 14, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
1,600
-1.0%
49.27
78,832
USD
|
1,600
-1.0%
|
49.27
|
78,832
USD
|
|
Dec. 14, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
7,718
-4.6%
48.75
376,253
USD
|
7,718
-4.6%
|
48.75
|
376,253
USD
|
|
Dec. 14, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
6,564
-3.8%
47.61
312,512
USD
|
6,564
-3.8%
|
47.61
|
312,512
USD
|
|
Dec. 14, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
7,018
-3.9%
46.72
327,881
USD
|
7,018
-3.9%
|
46.72
|
327,881
USD
|
|
Dec. 14, 2021 |
Dec. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
2,100
-1.2%
45.68
95,928
USD
|
2,100
-1.2%
|
45.68
|
95,928
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
5
-0.0%
55.54
278
USD
|
5
-0.0%
|
55.54
|
278
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
600
-0.5%
54.58
32,748
USD
|
600
-0.5%
|
54.58
|
32,748
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,031
-0.8%
53.66
55,323
USD
|
1,031
-0.8%
|
53.66
|
55,323
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,822
-1.4%
52.37
95,418
USD
|
1,822
-1.4%
|
52.37
|
95,418
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,045
-0.8%
51.08
53,379
USD
|
1,045
-0.8%
|
51.08
|
53,379
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
900
-0.7%
50.42
45,378
USD
|
900
-0.7%
|
50.42
|
45,378
USD
|
|
Dec. 13, 2021 |
Dec. 10, 2021 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
2,097
-1.6%
49.32
103,424
USD
|
2,097
-1.6%
|
49.32
|
103,424
USD
|
|
Nov. 22, 2021 |
Nov. 18, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
20,000
-4.8%
54.27
1,085,400
USD
|
20,000
-4.8%
|
54.27
|
1,085,400
USD
|
|
Oct. 25, 2021 |
Oct. 22, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-7.1%
58.88
1,766,400
USD
|
30,000
-7.1%
|
58.88
|
1,766,400
USD
|
|
Oct. 25, 2021 |
Oct. 21, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
14,765
-3.6%
60.63
895,202
USD
|
14,765
-3.6%
|
60.63
|
895,202
USD
|
|
Oct. 25, 2021 |
Oct. 21, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
15,235
-3.6%
59.82
911,358
USD
|
15,235
-3.6%
|
59.82
|
911,358
USD
|
|
Oct. 4, 2021 |
Oct. 1, 2021 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
11,844
-9.9%
59.68
706,862
USD
|
11,844
-9.9%
|
59.68
|
706,862
USD
|
|
Oct. 4, 2021 |
Oct. 1, 2021 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
21,844
-15.4%
58.96
1,287,966
USD
|
21,844
-15.4%
|
58.96
|
1,287,966
USD
|
|
Oct. 4, 2021 |
Oct. 1, 2021 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
16,312
-10.3%
58.03
946,634
USD
|
16,312
-10.3%
|
58.03
|
946,634
USD
|
|
Sept. 14, 2021 |
Sept. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
800
-0.8%
67.46
53,965
USD
|
800
-0.8%
|
67.46
|
53,965
USD
|
|
Sept. 14, 2021 |
Sept. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,391
-8.0%
66.84
560,879
USD
|
8,391
-8.0%
|
66.84
|
560,879
USD
|
|
Sept. 14, 2021 |
Sept. 13, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
15,809
-13.1%
65.94
1,042,414
USD
|
15,809
-13.1%
|
65.94
|
1,042,414
USD
|
|
June 16, 2021 |
June 14, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
400
-0.4%
90.76
36,303
USD
|
400
-0.4%
|
90.76
|
36,303
USD
|
|
June 16, 2021 |
June 14, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,220
-7.9%
89.68
737,155
USD
|
8,220
-7.9%
|
89.68
|
737,155
USD
|
|
June 16, 2021 |
June 14, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
16,380
-13.6%
89.11
1,459,587
USD
|
16,380
-13.6%
|
89.11
|
1,459,587
USD
|
|
April 26, 2021 |
April 23, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-7.1%
85.24
2,557,284
USD
|
30,000
-7.1%
|
85.24
|
2,557,284
USD
|
|
April 26, 2021 |
April 22, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-7.1%
85.54
2,566,212
USD
|
30,000
-7.1%
|
85.54
|
2,566,212
USD
|
|
March 16, 2021 |
March 15, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
1,018
-1.1%
94.59
96,297
USD
|
1,018
-1.1%
|
94.59
|
96,297
USD
|
|
March 16, 2021 |
March 15, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
3,205
-3.2%
93.75
300,461
USD
|
3,205
-3.2%
|
93.75
|
300,461
USD
|
|
March 16, 2021 |
March 15, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,404
-7.8%
92.64
778,578
USD
|
8,404
-7.8%
|
92.64
|
778,578
USD
|
|
March 16, 2021 |
March 15, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,416
-7.2%
91.94
773,782
USD
|
8,416
-7.2%
|
91.94
|
773,782
USD
|
|
March 16, 2021 |
March 15, 2021 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
3,957
-3.3%
90.89
359,654
USD
|
3,957
-3.3%
|
90.89
|
359,654
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
800
-1.1%
86.70
69,360
USD
|
800
-1.1%
|
86.70
|
69,360
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,900
-3.8%
85.50
247,956
USD
|
2,900
-3.8%
|
85.50
|
247,956
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,728
-3.4%
84.20
229,705
USD
|
2,728
-3.4%
|
84.20
|
229,705
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,480
-3.0%
83.46
206,989
USD
|
2,480
-3.0%
|
83.46
|
206,989
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,993
-3.5%
81.60
244,224
USD
|
2,993
-3.5%
|
81.60
|
244,224
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
5,174
-5.7%
80.73
417,722
USD
|
5,174
-5.7%
|
80.73
|
417,722
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
4,627
-4.9%
79.58
368,236
USD
|
4,627
-4.9%
|
79.58
|
368,236
USD
|
|
March 9, 2021 |
March 8, 2021 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
3,298
-3.4%
78.60
259,236
USD
|
3,298
-3.4%
|
78.60
|
259,236
USD
|
|
Feb. 19, 2021 |
Feb. 18, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
5,547
-1.4%
103.16
572,206
USD
|
5,547
-1.4%
|
103.16
|
572,206
USD
|
|
Feb. 19, 2021 |
Feb. 18, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
8,602
-2.1%
102.26
879,661
USD
|
8,602
-2.1%
|
102.26
|
879,661
USD
|
|
Feb. 19, 2021 |
Feb. 18, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
2,602
-0.6%
101.42
263,883
USD
|
2,602
-0.6%
|
101.42
|
263,883
USD
|
|
Feb. 19, 2021 |
Feb. 18, 2021 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
1,848
-0.4%
100.48
185,691
USD
|
1,848
-0.4%
|
100.48
|
185,691
USD
|
|